Smith & Nephew | Smith & Nephew receives FDA 510k clearance for a 30-year knee

Shared by Mr. Aaron Swedberg

Smith & Nephew receives FDA 510k clearance for a 30-year knee New wear simulator data shows Smith & Nephew’s exclusive VERILAST◊ technology reduces leading cause of knee implant failure by 81-percent over 30-year spanMemphis, Tenn. April 22, 2010 – As evidence of its drive to return knee pain sufferers to a lifetime of physical activity, Smith & Nephew NYSE: SNN, LSE: SN Orthopaedics Division today announces the results of unprecedented testing on its VERILAST technology for knee replacement implants. After simulating 30 years of physical activity on the company’s LEGION◊ knee replacement, VERILAST technology produced an 81-percent reduction in wear, the leading cause of knee replacement failure.

via Smith & Nephew | Smith & Nephew receives FDA 510k clearance for a 30-year knee.